COVID-19 Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (Corticosteroids, Anti-viral, Monoclonal Antibodies, Kinase Inhibitors, Others (anti-inflammatory drugs, convalescent plasma, others)), By Region, And By Segment Forecasts, 2025-2034

Report Id: 1184 Pages: 190 Last Updated: 25 May 2025 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Global COVID-19 Therapeutics Market is expected to grow at a 15.0% CAGR during the forecast period for 2025-2034.

The increasing outbreak of covid-19 is increasing the demand for coronavirus vaccines or therapies, which will result in the expansion of the COVID-19 therapeutics market during the forecast period. According to the World Health Organization (WHO), globally, 175,847,347 confirmed cases of COVID-19, including 3,807,276 deaths, were reported to WHO as of 15 June 2021. Covid-19 cases are increasing day by day, and there is no officially approved drug for COVID-19. Many countries are facing a shortage of drugs likely to offer growth opportunities for pharmaceutical drug manufacturers. Leading market players are also developing innovative and efficient covid-19 drug therapies, resulting in overall market growth. 

COVID-19 Therapeutics Market

Major factors responsible for the growth of the COVID 19 therapeutic market are the fast adoption of advanced technologies, the growing number of corona patients, increasing healthcare expenditures, rising awareness about coronavirus, and increasing efforts by the pharmaceutical companies to develop covid-19 therapeutic drugs. For instance, Eli Lilly and Company is donating COVID-19 therapies to Direct Relief, enabling the humanitarian organization to provide COVID-19 treatments at no cost to low- and lower-middle-income countries most heavily impacted by the pandemic. Furthermore, increasing research investments for the R&D of covid-19 therapeutic drugs is anticipated to drive market growth in the future. However, the high cost required to validate therapies, and long-term clinical trials limit the COVID-19 therapeutics market growth.

 Market Segmetation

The COVID-19 therapeutics market can be segmented into Drug Class, and Region. By Drug Claas, the market can be divided into Corticosteroids (Dexamethasone, Hydrocortisone, Methylprednisolone, Others (Prednisone, Others)), Anti-viral (Remdesivir, Nirmatrelvir, Others (Ivermectin, Others)), Monoclonal Antibodies (Sotrovimab, Casirivimab plus imdevimab, Others (Bamlanivimab plus etesevimab, Tixagevimab plus, cilgavimab, others), Kinase Inhibitors (Baricitinib, Others (Tofacitinib, Others)),Others (anti-inflammatory drugs, convalescent plasma, others). Regionally, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America is expected to dominate the COVID-19 therapeutics market in the coming future.

Competitive Landscape

Some major key players in the COVID-19 Therapeutics Market:

  • AstraZeneca plc,
  • Celltrion Healthcare Co.,Ltd,
  • Pfizer Inc.,
  • Ridgeback Biotherapeutics,
  • Merck & Co.,
  • Veru Inc.,
  • Gilead Sciences, Inc.,
  • GSK plc,
  • Shionogi & Company, Limited,
  • NRx Pharmaceuticals, Inc.,
  • Kintor Pharma-B,
  • Regeneron Pharmaceuticals,
  • CytoDyn,
  • Atea Pharmaceuticals, Inc.,
  • Amarin Corporation,
  • APEIRON Biologics AG,
  • Abivax SA,
  • Alexion Pharmaceuticals,
  • Bellerophon Therapeutics,
  • Blade Therapeutics, Inc,
  • Roivant Sciences,
  • Synairgen,
  • Sorrento Therapeutics,
  • Fulcrum Therapeutics,
  • Ono Pharmaceutical Co., Ltd.,
  • Revive Therapeutics Ltd.,
  • other prominent players

COVID-19 Therapeutics Market Report Scope

Report Attribute Specifications
Growth Rate CAGR CAGR of 15.0% from 2025 to 2034
Quantitative Units Representation of revenue in US$ Bn,and CAGR from 2025 to 2034
Historic Year 2021 to 2024
Forecast Year 2025 to 2034
Report Coverage The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends
Segments Covered By Drug Class
Regional Scope North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country Scope U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia
Competitive Landscape AstraZeneca plc, Celltrion Healthcare Co.,Ltd, Pfizer Inc., Ridgeback Biotherapeutics, Merck & Co., Veru Inc., Gilead Sciences, Inc., GSK plc, Shionogi & Company, Limited, NRx Pharmaceuticals, Inc., Kintor Pharma-B, Regeneron Pharmaceuticals, CytoDyn, Atea Pharmaceuticals, Inc., Amarin Corporation, APEIRON Biologics AG, Abivax SA, Alexion Pharmaceuticals, Bellerophon Therapeutics, Blade Therapeutics, Inc, Roivant Sciences, Synairgen, Sorrento Therapeutics, Fulcrum Therapeutics, Ono Pharmaceutical Co., Ltd., Revive Therapeutics Ltd., and other prominent players
Customization Scope Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.
Pricing And Available Payment Methods Explore pricing alternatives that are customized to your particular study requirements.

Market Segmentation of COVID-19 Therapeutics Market 

Global COVID-19 therapeutics Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 202 to 2030 based on Drug Class

  • Corticosteroids
    • Dexamethasone
    • Hydrocortisone
    • Methylprednisolone
    • Others (Prednisone, Others)
  • Anti-viral
    • Remdesivir
    • Nirmatrelvir
    • Others (Ivermectin, Others)
  • Monoclonal Antibodies
    • Sotrovimab
    • Casirivimab plus imdevimab
    • Others (Bamlanivimab plus etesevimab, Tixagevimab plus, cilgavimab, others)
  • Kinase Inhibitors
    • Baricitinib
    • Others (Tofacitinib, Others)
  • Others (anti-inflammatory drugs, convalescent plasma, others)

COVID-19 Therapeutics Market

Global COVID-19 therapeutics Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 based on Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

North America COVID-19 therapeutics market revenue (US$ Million) by Country, 2020 to 2030

  • U.S.
  • Canada

Europe COVID-19 therapeutics market revenue (US$ Million) by Country, 2020 to 2030

  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific COVID-19 therapeutics market revenue (US$ Million) by Country, 2020 to 2030

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America COVID-19 therapeutics market revenue (US$ Million) by Country, 2020 to 2030

  • Brazil
  • Mexico
  • Rest of Latin America

The Middle East & Africa COVID-19 therapeutics market revenue (US$ Million) by Country, 2020 to 2030

  • GCC Countries
  • South Africa
  • Rest of the Middle East & Africa

 Competitive Landscape

  • Company Overview
  • Financial Performance
  • Key Development
  • Latest Strategic Developments

Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Download Free Brochure

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
5204
Security Code field cannot be blank!

Frequently Asked Questions

Some of the key Players of COVID-19 therapeutics market are AstraZeneca plc, Celltrion Healthcare Co.,Ltd, Pfizer Inc., Ridgeback Biotherapeutics,

COVID-19 Therapeutics Market is expected to grow at a 15.0 % CAGR during the forecast period for 2025-2034.

Drug Class are the key segments of the COVID-19 Therapeutics Market.

North America region is leading the COVID-19 Therapeutics Market.
Send Me the Sample Report Enquiry Before Buying